Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Krajewski

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The British Journal of Radiology|June 8, 2012
Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patientsE Thornton, S A Howard, J Jagannathan, et al.
Clinical Radiology|May 7, 2017
Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitorsF Alessandrino, S H Tirumani, K M Krajewski, et al.
Brain : a Journal of Neurology|January 29, 2000
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapyJ Kamholz, D Menichella, A Jani, et al.
The British Journal of Radiology|June 26, 2015
MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experienceA D Baheti, A B Shinagare, A C O'Neill, et al.
Neurology|March 14, 2007
CMT1X phenotypes represent loss of GJB1 gene functionM E Shy, C Siskind, E R Swan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The British Journal of Radiology|June 8, 2012
Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patientsE Thornton, S A Howard, J Jagannathan, et al.
Clinical Radiology|May 7, 2017
Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitorsF Alessandrino, S H Tirumani, K M Krajewski, et al.
Brain : a Journal of Neurology|January 29, 2000
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapyJ Kamholz, D Menichella, A Jani, et al.
The British Journal of Radiology|June 26, 2015
MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experienceA D Baheti, A B Shinagare, A C O'Neill, et al.
Neurology|March 14, 2007
CMT1X phenotypes represent loss of GJB1 gene functionM E Shy, C Siskind, E R Swan, et al.
Pageof 2